• This record comes from PubMed

Neonatal screening in the Czech Republic: increased prevalence of selected diseases in low birthweight neonates

. 2018 Nov ; 177 (11) : 1697-1704. [epub] 20180822

Language English Country Germany Media print-electronic

Document type Journal Article

Links

PubMed 30136145
DOI 10.1007/s00431-018-3230-y
PII: 10.1007/s00431-018-3230-y
Knihovny.cz E-resources

Neonates with low birthweight (LBW) represent a vulnerable population. This retrospective study analyzed the birth frequency of diseases detected by neonatal screening (NBS) in normal and LBW neonates in the Czech Republic. Between years 2002 and 2016, the number of screened disorders in the Czech Republic gradually increased from two to 13. Prevalence of screened diseases was calculated for cohorts ranging from 777,100 to 1,277,283 neonates stratified by birthweight. Odds ratio of the association of LBW with each disease was calculated and statistical significance was evaluated using the chi-square test or Fisher's exact test, as appropriate. Three diseases were associated with higher risk of prevalence in LBW neonates, namely congenital hypothyroidism (OR 2.50, CI 1.92; 3.25), cystic fibrosis (OR 2.44, CI 1.51; 3.94), and long chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD) (OR 7.74, CI 2.18; 27.42).Conclusion: Although the underlying mechanisms are not well understood, results can be hypothesized that LBW (respectively prematurity) may lead to the secondary and often transitory hypothyroidism while cystic fibrosis and LCHADD may manifest already prenatally and result into preterm birth and LBW. What is Known: • The percentage of low birthweight (LBW) neonates in the Czech Republic has been increasing. • Previously published studies reported positive association between LBW and congenital hypothyroidism and cystic fibrosis. What is New: • The association between LCHADD and LBW has not yet been described. • LBW can be the first manifestation of cystic fibrosis and LCHADD.

See more in PubMed

J Clin Endocrinol Metab. 2014 Feb;99(2):363-84 PubMed

Eur J Pediatr. 2012 Jun;171(6):935-40 PubMed

Clin Endocrinol (Oxf). 2004 Jun;60(6):711-8 PubMed

J Pediatr Endocrinol Metab. 2006 Nov;19(11):1291-8 PubMed

Korean J Pediatr. 2015 Jun;58(6):224-9 PubMed

Arch Argent Pediatr. 2012 Aug;110(4):e63-6 PubMed

Arch Dis Child. 2009 Mar;94(3):235-8 PubMed

J Cyst Fibros. 2014 Jan;13(1):15-23 PubMed

J Med Screen. 2005;12(4):166-9 PubMed

Orphanet J Rare Dis. 2015 Feb 22;10:21 PubMed

Semin Perinatol. 1999 Apr;23(2):100-12 PubMed

Obstet Gynecol. 2014 Jul;124(1):16-22 PubMed

J Matern Fetal Neonatal Med. 2006 Dec;19(12):773-82 PubMed

Eur J Endocrinol. 2016 Nov;175(5):395-402 PubMed

Lancet Diabetes Endocrinol. 2017 Sep;5(9):743-756 PubMed

J Cyst Fibros. 2009 Jan;8(1):71-8 PubMed

Eur J Pediatr. 1999 Mar;158(3):264 PubMed

J Paediatr Child Health. 2012 Sep;48(9):784-8 PubMed

J Pediatr. 2005 Sep;147(3):316-20 PubMed

J Inherit Metab Dis. 2011 Jun;34(3):827-33 PubMed

J Pediatr Endocrinol Metab. 2017 May 24;30(6):677-681 PubMed

J Pediatr. 2013 Jan;162(1):177-82 PubMed

Mol Hum Reprod. 1996 Sep;2(9):693-8 PubMed

Teratology. 2000 Jul;62(1):36-41 PubMed

Acta Med Iran. 2012;50(11):735-9 PubMed

J Clin Endocrinol Metab. 2010 Sep;95(9):4133-60 PubMed

Clin Endocrinol (Oxf). 2005 Apr;62(4):444-8 PubMed

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...